A Retrospective Study on the Expression of E-Cadherin in Endometrial Carcinoma
- PMID: 39493171
- PMCID: PMC11531303
- DOI: 10.7759/cureus.70767
A Retrospective Study on the Expression of E-Cadherin in Endometrial Carcinoma
Abstract
E-cadherin is a cell adhesion molecule crucial for maintaining cellular integrity and survival. E-cadherin is the focus of this study, which aims to evaluate its immunohistochemical staining patterns in endometrial carcinoma (EC). Material and methods In this retrospective study, 25 formalin-fixed, paraffin-embedded tissue blocks of EC were retrieved from the Department of Pathology at Saveetha Medical College. These samples, collected between September 2020 and May 2023, were identified using unique histopathology numbers. Results The analysis revealed that E-cadherin expression decreased as the endometrial tissue progressed from normal to carcinoma. This reduction was more pronounced in cancers with greater depth of invasion and in more advanced stages compared to those with less invasive depth and earlier stages. Additionally, E-cadherin expression was higher in grade 1 tumors but became heterogeneous or negative in grade 3 tumors. Conclusion The downregulation of E-cadherin is likely due to disruptions in the cadherin-catenin complex, which is linked to the potential for local and distant metastasis in cancer. This study underscores the significance of cell adhesion molecule expression in predicting the prognosis of EC.
Keywords: cancer metastasis; dedifferentiated carcinoma; e-cadherin expression; endometrial carcinoma; endometrioid carcinoma; serous carcinoma.
Copyright © 2024, Jayaraman et al.
Conflict of interest statement
Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures








References
-
- Endometrial cancer: an overview of pathophysiology, management, and care. Passarello K, Kurian S, Villanueva V. Semin Oncol Nurs. 2019;35:157–165. - PubMed
-
- E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas. Yalta T, Atay L, Atalay F, Caydere M, Gonultas M, Ustun H. J Int Med Res. 2009;37:163–168. - PubMed
-
- E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium. Carico E, Atlante M, Giarnieri E, Raffa S, Bucci B, Giovagnoli MR, Vecchione A. https://pubmed.ncbi.nlm.nih.gov/21187480/ Anticancer Res. 2010;30:4993–4997. - PubMed
LinkOut - more resources
Full Text Sources